Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Peretz

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Anticancer Research|January 12, 2000
Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancerB Nisman, G Amir, J Lafair, et al.
The American Journal of Pathology|October 6, 2000
Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesisY Friedmann, I Vlodavsky, H Aingorn, et al.
Israel Journal of Medical Sciences|January 1, 1994
Taxol: initial Israeli experience with a novel anticancer agentA Sulkes, U Beller, T Peretz, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literatureO Lyass, G Brufman, D Z Edelmann, et al.
The Journal of Biological Chemistry|November 15, 1996
Phosphorylation of a K+ channel alpha subunit modulates the inactivation conferred by a beta subunit. Involvement of cytoskeletonG Levin, D Chikvashvili, D Singer-Lahat, et al.
Cancer|May 20, 1998
Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?B Nisman, J Lafair, N Heching, et al.
British Journal of Cancer|December 19, 2007
Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survivalB Nisman, H Biran, N Heching, et al.
The American Journal of Psychiatry|June 1, 2000
Transmission of response to trauma? Second-generation Holocaust survivors' reaction to cancerL Baider, T Peretz, P E Hadani, et al.
Archives of Dermatology|December 15, 2000
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicinM Lotem, A Hubert, O Lyass, et al.
Metabolism: Clinical and Experimental|May 1, 1997
Tumor necrosis factor inhibits the transcriptional rate of glucose-6-phosphatase in vivo and in vitroS Metzger, N Begleibter, V Barash, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Anticancer Research|January 12, 2000
Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancerB Nisman, G Amir, J Lafair, et al.
The American Journal of Pathology|October 6, 2000
Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesisY Friedmann, I Vlodavsky, H Aingorn, et al.
Israel Journal of Medical Sciences|January 1, 1994
Taxol: initial Israeli experience with a novel anticancer agentA Sulkes, U Beller, T Peretz, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literatureO Lyass, G Brufman, D Z Edelmann, et al.
The Journal of Biological Chemistry|November 15, 1996
Phosphorylation of a K+ channel alpha subunit modulates the inactivation conferred by a beta subunit. Involvement of cytoskeletonG Levin, D Chikvashvili, D Singer-Lahat, et al.
Cancer|May 20, 1998
Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?B Nisman, J Lafair, N Heching, et al.
British Journal of Cancer|December 19, 2007
Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survivalB Nisman, H Biran, N Heching, et al.
The American Journal of Psychiatry|June 1, 2000
Transmission of response to trauma? Second-generation Holocaust survivors' reaction to cancerL Baider, T Peretz, P E Hadani, et al.
Archives of Dermatology|December 15, 2000
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicinM Lotem, A Hubert, O Lyass, et al.
Metabolism: Clinical and Experimental|May 1, 1997
Tumor necrosis factor inhibits the transcriptional rate of glucose-6-phosphatase in vivo and in vitroS Metzger, N Begleibter, V Barash, et al.
Pageof 11